Porphyria Cutanea Tarda
📧 Sign up to get email alerts when something new happens for Porphyria Cutanea Tarda.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Longitudinal Study of the Porphyrias
This longitudinal clinical trial focuses on acute hepatic porphyrias and porphyria cutanea tarda and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Harvoni Treatment Porphyria Cutanea Tarda [Phase 2]
Phase 2 clinical trial updating Harvoni treatment for Porphyria Cutanea Tarda and Hepatitis C has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda [Phase 2]
Phase 2 trial evaluating hydroxychloroquine with phlebotomy for porphyria cutanea tarda has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda [Phase 3]
This update reports the completion and posted results of a Phase 3 pilot trial evaluating deferasirox for treating porphyria cutanea tarda.
-
CLINICAL_TRIALS trial_result · 2011-01-27Clinical Trial Update: Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda [Phase 2]
A Phase 2 clinical trial is evaluating the safety and efficacy of oral deferasirox in patients with porphyria cutanea tarda.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.